Our data suggest that thyroid cancer cell lines with lower Wee1 expression rely on Wee1 activity, and interrupting Wee1 with adavosertib impairs cell growth more significantly than thyroid cancer cells with higher Wee1 expression. Here, WEE1 is linked to thyroid gland carcinoma.